NCT05588973

Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus

Pilot Double-blind Randomized Controlled Clinical Trial for the Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Angelos Kassianos · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

The treatment of cancer as a multidimensional disease has improved in recent years with the development of new chemotherapies, targeted biological therapies or radiation therapy protocols and have led to an overall improvement in the survival of oncology patients. These treatments often cause adverse effects on the skin, which can be accompanied by physical and mental suffering and have a significant impact on patients' quality of life. Improving the quality of life of patients is today a therapeutic challenge. The objective of this clinical study is to assess the tolerability of an innovative skin cosmetic product that will be developed specifically for use during curative anticancer treatments, as well as to study the impact on quality of life of skin side effects caused by the treatments.

Conditions

• Head and Neck Cancer
• Breast Cancer

Interventions

Type	Name	Description
OTHER	MEDISKIN cream	MEDISKIN cream with collagen
OTHER	Panthenol cream	Panthenol cream

Timeline

• Start date: 2022-12-01
• Primary completion: 2023-06-01
• Completion: 2023-06-01
• First posted: 2022-10-20
• Last updated: 2022-12-06

Locations

1 site across 1 country: Cyprus